Skip to main content

Table 3 Adjusted odds ratios (95% confidence intervals) of NAFLD according to BMI and HOMA-IR status and serum SHBG quartiles using adjusted logistic regression

From: Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults

 

SHBG (nmol/L)

p for trend

Quartile 1

Quartile 2

Quartile 3

Quartile 4

BMI < 24 kg/m2

(N = 1696)

<  45.03

45.03–60.90

60.91–80.98

>  80.98

 

 Model 1

1.00

0.50 (0.38–0.66)

0.23 (0.17–0.31)

0.15 (0.11–0.21)

<  0.001

 Model 2

1.00

0.56 (0.42–0.75)

0.29 (0.21–0.40)

0.24 (0.17–0.34)

<  0.001

 Model 3

1.00

0.60 (0.46–0.84)

0.35 (0.25–0.48)

0.31 (0.21–0.45)

<  0.001

BMI ≥ 24 kg/m2

(N = 1216)

<  32.70

32.70–43.10

43.11–56.30

>  56.30

 

 Model 1

1.00

0.53 (0.34–0.83)

0.33 (0.21–0.51)

0.17 (0.11–0.27)

<  0.001

 Model 2

1.00

0.57 (0.36–0.89)

0.37 (0.24–0.57)

0.21 (0.14–0.32)

<  0.001

 Model 3

1.00

0.70 (0.44–1.12)

0.49 (0.30–0.78)

0.31 (0.19–0.51)

<  0.001

p for interaction

–

–

–

–

0.150

HOMA-IR < 2

(N = 1780)

<  45.20

45.20–60.10

60.11–79.38

>  79.38

 

 Model 1

1.00

0.55 (0.42–0.72)

0.29 (0.22–0.39)

0.17 (0.13–0.23)

<  0.001

 Model 2

1.00

0.64 (0.49–0.85)

0.40 (0.29–0.54)

0.32 (0.23–0.44)

<  0.001

 Model 3

1.00

0.67 (0.50–0.89)

0.43 (0.31–0.59)

0.34 (0.24–0.49)

<  0.001

HOMA-IR ≥ 2

(N = 1132)

<  31.50

31.50–41.60

41.61–55.68

>  55.68

 

 Model 1

1.00

0.76 (0.47–1.21)

0.41 (0.27–0.64)

0.16 (0.10–0.25)

<  0.001

 Model 2

1.00

0.84 (0.52–1.36)

0.46 (0.29–0.73)

0.21 (0.14–0.33)

<  0.001

 Model 3

1.00

0.83 (0.50–1.36)

0.43 (0.27–0.70)

0.22 (0.13–0.36)

<  0.001

p for interaction

–

–

–

–

0.021

  1. Model 1: Adjusted for age, sex and household income
  2. Model 2: Adjusted for the variables in Model 1 plus WHR, trunk fat, current smoking and drinking, physical activity (MET), hypertension and diabetes
  3. Model 3: Adjusted for the variables in Model 2 plus serum glucose, insulin resistance (HOMA-IR), TG, HDL-C, ALT, UA, testosterone and DHEAS levels
  4. NAFLD nonalcoholic fatty liver disease; SHBG sex hormone-binding globulin; BMI body mass index; HOMA-IR homeostasis model assessment of insulin resistance